Microarray-based mutation detection and phenotypic characterization of patients with Leber congenital amaurosis

Suzanne Yzer, Bart P Leroy, Elfride De Baere, Thomy J de Ravel, Marijke N Zonneveld, Krysta Voesenek, Ulrich Kellner, Jose P Martinez Ciriano, Jan-Tjeerd H N de Faber, Klaus Rohrschneider, Ronald Roepman, Anneke I den Hollander, Johannes R Cruysberg, Françoise Meire, Ingele Casteels, Norka G van Moll-Ramirez, Rando Allikmets, L Ingeborgh van den Born, Frans P M Cremers

Research output: Contribution to journalArticleResearchpeer-review


PURPOSE: To test the efficiency of a microarray chip as a diagnostic tool in a cohort of northwestern European patients with Leber congenital amaurosis (LCA) and to perform a genotype-phenotype analysis in patients in whom pathologic mutations were identified.

METHODS: DNAs from 58 patients with LCA were analyzed using a microarray chip containing previously identified disease-associated sequence variants in six LCA genes. Mutations identified by chip analysis were confirmed by sequence analysis. On identification of one mutation, all protein coding exons of the relevant genes were sequenced. In addition, sequence analysis of the RDH12 gene was performed in 22 patients. Patients with mutations were phenotyped.

RESULTS: Pathogenic mutations were identified in 19 of the 58 patients with LCA (32.8%). Four novel sequence variants were identified. Mutations were most frequently found in CRB1 (15.5%), followed by GUCY2D (10.3%). The p.R768W mutation was found in 8 of 10 GUCY2D alleles, suggesting that it is a founder mutation in the northwest of Europe. In early childhood, patients with AIPL1 or GUCY2D mutations show normal fundi. Those with AIPL1-associated LCA progress to an RP-like fundus before the age of 8, whereas patients with GUCY2D-associated LCA still have relatively normal fundi in their mid-20s. Patients with CRB1 mutations present with distinct fundus abnormalities at birth and consistently show characteristics of RP12. Pathogenic GUCY2D mutations result in the most severe form of LCA.

CONCLUSIONS: Microarray-based mutation detection allowed the identification of 32% of LCA sequence variants and represents an efficient first-pass screening tool. Mutations in CRB1, and to a lesser extent, in GUCY2D, underlie most LCA cases in this cohort. The present study establishes a genotype-phenotype correlation for AIPL1, CRB1, and GUCY2D.

Original languageEnglish
Pages (from-to)1167-76
Number of pages10
JournalInvestigative ophthalmology & visual science
Issue number3
Publication statusPublished - Mar 2006


  • Adaptor Proteins, Signal Transducing
  • Alcohol Oxidoreductases/genetics
  • Blindness/congenital
  • Carrier Proteins/genetics
  • Child
  • Child, Preschool
  • DNA Mutational Analysis
  • Eye Proteins/genetics
  • Female
  • Genetic Testing/methods
  • Genotype
  • Guanylate Cyclase/genetics
  • Humans
  • Infant
  • Male
  • Membrane Proteins/genetics
  • Mutation
  • Nerve Tissue Proteins/genetics
  • Oligonucleotide Array Sequence Analysis/methods
  • Phenotype
  • Receptors, Cell Surface/genetics
  • Retinitis Pigmentosa/congenital
  • cis-trans-Isomerases


Dive into the research topics of 'Microarray-based mutation detection and phenotypic characterization of patients with Leber congenital amaurosis'. Together they form a unique fingerprint.

Cite this